MedTrace Logo

Freeze All Strategy Versus Fresh Embryo Transfer After GnRH Analogue Trigger

NCT05362734 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1396

Last updated 2023-07-07

No results posted yet for this study

Summary

Ovarian hyperstimulation syndrome (OHSS) is one of the most dangerous complications of assisted reproduction technology (ART), described in approximatively 3 to 10% of stimulation cycles although an underestimation of the real incidence has been suggested.

The use in clinical practice of GnRH antagonist has made it possible to perform the trigger with GnRH analogues, with the advantage of considerably reducing the risk of OHSS.

Conditions

  • Ovarian Hyperstimulation Syndrome
  • Pregnancy Related

Interventions

BEHAVIORAL

obstetric outcomes after fresh versus cryopreserved embryo transfer

measure of ongoing pregnancy rate, delivery rate, abortion rate, ectopic pregnancy rate, multiple birth rate, ovarian hyperstimulation syndrome incidence, drop out rate

Sponsors & Collaborators

  • Istituto Clinico Humanitas

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-01
Primary Completion
2020-12-31
Completion
2020-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05362734 on ClinicalTrials.gov